MLN2704 (DM1 conjugated monoclonal antibody MLN591)

DRUG2 trials

Sponsors

Millennium Pharmaceuticals, Inc.

Conditions

Prostate CancerProstatic Neoplasms

Phase 1

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

CompletedNCT00052000

Millennium Pharmaceuticals, Inc.Prostate Cancer

Start: 2002-11-30Target: 29Updated: 2007-03-01

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

CompletedNCT00070837

Millennium Pharmaceuticals, Inc.Prostatic Neoplasms

Start: 2003-10-31End: 2004-10-31Target: 46Updated: 2007-07-13